| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 9 |
| 1 | ASPIRIN 325 MG | 8 |
| 2 | ASPIRIN 81 MG | 8 |
| 3 | PREDNISONE | 6 |
| 4 | SILDENAFIL CITRATE | 6 |
| 5 | SODIUM CHLORIDE | 6 |
| 6 | SODIUM CHLORIDE TABLET | 6 |
| 7 | SODIUM CHLORIDE TABLETS | 6 |
| 8 | VALSARTAN | 6 |
| 9 | ALENDRONATE SODIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEFAZODONE HYDROCHLORIDE | 1 | 0.0083 |
| 1 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 2 | NIPOCALIMAB-AAHU | 1 | 0.0031 |
| 3 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 4 | ALGLUCOSIDASE ALFA | 2 | 0.0008 |
| 5 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 6 | CEFADROXIL | 1 | 0.0005 |
| 7 | NITRIC OXIDE | 2 | 0.0004 |
| 8 | NEOMYCIN OINTMENT | 1 | 0.0004 |
| 9 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 1 | Cannabinoid [EPC] | 2 | 0.0002 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 3 | 0.0002 |
| 7 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 9 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |